Klaria Pharma Holding AB (KLAR) — Capital Reinvestment Ratio
Latest as of March 2020:
0.07x
Klaria Pharma Holding AB (KLAR) has a Capital Reinvestment Ratio of 0.07x as of March 2020, meaning it reinvests 0% of its operating cash flow (Skr442.00K) in capital expenditures (Skr33.00K). See KLAR FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
Skr442.00K
SEK
Capital Expenditures
Skr33.00K
SEK
Data as of
Mar 2020
Most recent filing
Annual Capital Reinvestment Ratio for Klaria Pharma Holding AB (None–None)
Year-by-year Capital Reinvestment Ratio for Klaria Pharma Holding AB from None to None. For live market cap and broader valuation context, see how much is Klaria Pharma Holding AB worth.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow